Robust preclinical evidence in somatic cell genome editing: A key driver of responsible and efficient therapeutic innovations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Robust preclinical evidence in somatic cell genome editing: A key driver of responsible and efficient therapeutic innovations

Published:2021-10 Issue:10 Volume:26 Page:2238-2243
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Bittlinger Merlin,Schwietering Johannes,Strech Daniel

Funder

Bundesministerium für Bildung und Forschung

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference54 articles.

1. Search-and-replace genome editing without double-strand breaks or donor DNA;Anzalone;Nature,2019

2. The next generation of CRISPR-Cas technologies and applications;Pickar-Oliver;Nat Rev Mol Cell Biol,2019

3. Genome editing with engineered zinc finger nucleases;Urnov;Nat Rev Genet,2010

4. First clinical application of TALEN engineered universal CAR19 T cells in B-ALL;Qasim;Blood,2015

5. Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells;Qasim;Sci Transl Med,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Integrity in Emerging Technologies: Gene Editing and Artificial Intelligence (AI) Research in Medicine;Reconstructing Research Integrity;2023

2. Risk assessment in gene therapy and somatic genome-editing: An expert interview study;Gene and Genome Editing;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP